GENFIT: 2019 Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

January 10, 2020
Supporting Materials:

GENFIT:  2019 Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Lille (France), Cambridge (Massachusetts, United States), January 10, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced  the second half-year 2019 report of the liquidity contract with Crédit Industriel et Commercial.

Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity account as of December 31, 2019:

  • 18,132 shares
  • €1,023,262.27

During the second half of 2019, total trading was:

  • On the buy side: 1,344,696 shares for a total amount of €20,431,854.85
  • On the sell side: 1,380,676 shares for a total amount of €21,070,894.13

During this same period in the second half of 2019, the number of trades were:

  • On the buy side: 3,843
  • On the sell side: 5,167

As a reminder, the following resources appeared on the liquidity account as of June 30, 2019:

  • 27, 911 shares
  • €769 849,43

ABOUT GENFIT

GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning almost two decades. Its most advanced drug candidate, elafibranor, is currently being evaluated in a pivotal Phase 3 clinical trial (“RESOLVE-IT”) as a potential treatment for NASH, and GENFIT plans to initiate a Phase 3 clinical trial of elafibranor in PBC in 2020, following its positive Phase 2 results. As part of GENFIT’s comprehensive approach to clinical management of patients with NASH, the company is also developing a new, non-invasive blood-based diagnostic test, NIS4, which, if approved, could enable easier identification of patients with NASH. With facilities in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 200 employees. GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and in compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com

CONTACT

GENFIT | Investors

Naomi EICHENBAUM – Investor Relations | Tel: +1 (617) 714 5252 | investors@genfit.com

PRESS RELATIONS | Media

Hélène LAVIN – Press relations | Tel: +333 2016 4000 | helene.lavin@genfit.com

GENFIT | 885 Avenue Eugène Avinée, 59120 Loos - FRANCE | +333 2016 4000 | www.genfit.com      

 

APPENDIX

H2 2019

 

Buy side

Sell side

Date

Number of executions

Number of shares

Traded amount in EUR

Number of executions

Number of shares

Traded amount in EUR

TOTAL

3 843

1 344 696

20 431 854,85

5 167

1 380 676

21 070 894,13

01/07/2019

18

6 501

116 152,79

36

11 001

197 687,79

02/07/2019

28

11 351

201 767,80

28

5 501

98 857,80

03/07/2019

11

2 001

35 267,69

63

17 001

303 467,69

04/07/2019

22

13 355

236 058,24

52

15 588

277 229,49

05/07/2019

44

15 001

261 692,70

46

6 017

105 596,10

08/07/2019

49

18 001

306 672,41

26

4 461

76 508,41

09/07/2019

45

22 401

377 412,90

142

31 560

531 941,65

10/07/2019

17

11 065

189 281,99

121

27 265

465 894,01

11/07/2019

68

29 001

492 197,12

61

18 606

318 434,37

12/07/2019

60

19 988

335 628,86

105

27 080

455 897,36

15/07/2019

67

17 631

297 073,00

49

18 501

313 136,80

16/07/2019

9

2 378

40 418,36

55

13 300

226 024,75

17/07/2019

87

18 235

307 617,99

89

16 568

279 698,45

18/07/2019

42

25 629

436 999,55

73

23 001

396 046,80

19/07/2019

130

37 695

628 644,45

3

401

6 865,10

22/07/2019

27

11 072

180 779,85

126

30 700

504 183,80

23/07/2019

23

16 001

259 516,40

93

22 016

358 656,27

24/07/2019

11

5 001

80 186,17

78

18 001

290 721,17

25/07/2019

59

23 001

367 491,10

23

6 001

97 366,10

26/07/2019

19

18 284

290 972,68

82

24 618

393 018,85

29/07/2019

29

11 000

179 756,47

161

46 383

769 785,24

30/07/2019

30

14 950

239 533,00

 

 

 

31/07/2019

18

3 500

55 240,00

18

6 500

103 309,77

01/08/2019

13

5 001

80 486,00

7

5 001

80 876,00

02/08/2019

4

1 200

18 940,00

 

 

 

05/08/2019

29

16 001

238 925,60

52

13 120

194 230,37

06/08/2019

84

36 836

544 636,03

38

13 001

194 123,48

07/08/2019

65

30 001

441 524,73

43

21 744

322 057,03

08/08/2019

5

3 613

54 917,15

168

49 258

740 369,81

09/08/2019

183

56 001

832 676,01

17

4 613

69 520,72

12/08/2019

91

20 701

300 812,40

52

12 581

186 357,23

13/08/2019

17

3 607

51 840,43

181

35 727

518 724,87

14/08/2019

88

27 525

395 407,84

71

14 698

212 350,65

15/08/2019

49

30 684

420 239,62

59

21 359

295 077,57

16/08/2019

20

8 001

110 733,66

217

59 506

847 313,66

19/08/2019

110

30 111

458 570,74

37

9 001

136 634,70

20/08/2019

43

21 189

315 370,20

17

2 001

30 415,20

21/08/2019

2

5 001

78 064,85

84

24 073

372 255,37

22/08/2019

23

9 001

139 165,50

43

10 001

156 165,50

23/08/2019

13

7 501

115 440,41

1

1

15,41

26/08/2019

16

7 001

106 415,20

66

17 037

264 019,27

27/08/2019

6

10 001

156 715,56

37

10 001

157 565,56

28/08/2019

28

7 349

115 802,75

62

17 315

278 396,30

29/08/2019

73

25 873

418 591,47

18

8 501

137 986,23

30/08/2019

34

10 001

160 036,20

1

1

16,20

02/09/2019

43

13 985

214 772,55

12

4 100

64 270,60

03/09/2019

48

11 301

168 540,17

45

19 024

283 970,17

04/09/2019

4

5 502

85 335,72

36

9 358

145 692,28

05/09/2019

5

264

4 189,54

48

14 599

231 819,96

06/09/2019

25

9 412

146 486,40

39

10 499

162 714,90

09/09/2019

34

13 001

200 025,45

20

2 979

46 074,45

10/09/2019

81

15 001

226 565,44

79

17 007

258 094,74

11/09/2019

4

1 662

26 209,14

48

10 996

169 849,07

12/09/2019

14

7 001

110 215,85

47

13 758

217 361,31

13/09/2019

20

5 001

78 615,70

6

3 001

47 665,70

16/09/2019

11

5 001

80 085,58

38

13 001

208 245,58

17/09/2019

82

23 155

369 668,31

3

266

4 256,25

18/09/2019

21

7 089

112 640,10

77

15 164

241 965,97

19/09/2019

15

5 001

81 116,00

67

13 852

224 712,30

20/09/2019

22

5 319

85 227,87

9

2 152

34 659,88

23/09/2019

39

9 183

145 344,40

1

1

16,04

24/09/2019

44

8 601

133 762,70

1

1

15,70

25/09/2019

36

7 990

120 783,96

1

1

15,50

26/09/2019

13

13 001

195 565,09

3

1 001

14 815,10

27/09/2019

10

2 001

29 314,80

42

7 522

111 792,07

30/09/2019

5

1 001

14 644,72

15

3 501

51 524,72

01/10/2019

22

5 501

78 159,81

32

9 501

141 734,81

02/10/2019

36

9 501

128 889,02

1

1

14,02

03/10/2019

6

3 001

40 393,36

18

5 001

68 913,36

04/10/2019

11

3 221

43 124,66

38

13 500

182 230,00

07/10/2019

47

14 002

180 476,64

3

201

2 713,45

08/10/2019

19

9 501

116 756,45

43

14 501

181 077,70

09/10/2019

21

5 006

61 446,57

41

14 501

181 697,47

10/10/2019

21

6 001

74 807,90

12

3 127

39 220,76

11/10/2019

22

13 095

168 557,08

38

8 493

109 134,24

14/10/2019

2

2 001

26 813,08

29

12 458

167 828,01

15/10/2019

13

8 001

106 273,47

36

12 001

161 513,47

16/10/2019

28

7 001

93 513,44

25

9 001

121 213,44

17/10/2019

11

2 869

38 342,92

66

16 001

215 648,30

18/10/2019

68

14 501

192 853,50

3

499

6 661,80

21/10/2019

26

5 410

71 087,05

6

1 001

13 163,25

22/10/2019

28

9 578

125 446,06

11

2 501

32 953,13

23/10/2019

14

2 399

31 212,09

11

3 501

46 063,09

24/10/2019

6

1 501

19 978,28

15

3 501

46 923,28

25/10/2019

5

549

7 311,88

16

4 001

53 883,40

28/10/2019

1

1

13,50

72

24 070

331 879,50

29/10/2019

22

6 592

89 780,70

6

1 011

14 208,82

30/10/2019

17

7 036

93 979,00

1

1

13,50

31/10/2019

33

18 336

239 987,15

15

12 148

161 316,72

01/11/2019

21

8 959

114 469,85

1

1

12,87

04/11/2019

16

7 082

93 101,31

72

31 938

431 271,03

05/11/2019

28

15 541

207 766,85

11

6 344

86 565,06

06/11/2019

10

10 301

136 676,29

17

10 301

137 943,29

07/11/2019

3

2 001

26 613,30

4

2 001

26 733,30

08/11/2019

3

2 001

26 513,39

16

8 001

107 113,39

11/11/2019

23

14 251

208 615,45

41

22 589

325 342,23

12/11/2019

22

25 001

362 404,97

14

3 719

54 533,43

13/11/2019

3

3 001

42 514,53

10

3 001

42 664,53

14/11/2019

13

5 001

69 044,10

11

3 001

41 354,10

15/11/2019

3

2 001

27 113,80

10

2 001

27 257,84

18/11/2019

8

3 001

40 853,64

11

6 531

89 948,84

19/11/2019

5

1 529

21 173,74

9

3 546

49 066,54

20/11/2019

34

5 191

72 053,09

22

3 121

43 503,59

21/11/2019

46

14 783

204 329,80

28

5 172

71 599,35

22/11/2019

16

4 001

54 693,84

65

15 710

218 168,79

25/11/2019

54

14 001

194 214,02

65

21 720

307 021,67

26/11/2019

27

8 001

112 513,92

74

17 282

245 066,27

27/11/2019

34

13 151

190 719,61

36

7 001

101 714,61

28/11/2019

31

5 851

82 979,31

16

3 001

42 714,31

29/11/2019

23

7 001

98 674,07

44

7 085

100 573,67

02/12/2019

27

11 001

155 784,38

33

7 917

114 834,78

03/12/2019

16

4 001

55 814,00

51

12 001

168 914,00

04/12/2019

19

4 457

63 285,05

39

6 001

85 664,25

05/12/2019

44

13 545

194 053,51

43

7 001

101 264,28

06/12/2019

30

5 001

71 294,29

23

5 001

71 814,29

09/12/2019

16

4 001

57 004,34

12

2 001

28 514,34

10/12/2019

36

8 001

114 294,11

53

10 001

143 514,15

11/12/2019

10

3 001

43 614,63

16

6 001

88 094,63

12/12/2019

18

6 001

87 754,37

69

12 357

183 894,17

13/12/2019

20

5 001

75 215,23

12

2 001

30 515,23

16/12/2019

36

7 001

107 715,22

36

9 001

139 245,22

17/12/2019

5

3 001

46 525,60

19

4 001

62 565,60

18/12/2019

27

7 171

110 559,92

8

2 001

31 215,52

19/12/2019

22

6 831

105 874,30

63

13 001

208 015,30

20/12/2019

25

8 001

131 016,50

15

4 380

72 670,00

23/12/2019

6

2 001

32 916,53

11

3 001

49 816,53

24/12/2019

13

3 001

50 966,74

33

7 001

118 916,74

27/12/2019

24

9 691

177 372,00

13

5 026

95 233,50

30/12/2019

46

10 311

186 314,01

37

5 001

90 868,51

31/12/2019

16

2 710

47 454,27

28

4 001

70 817,67